Research Impact

h-index

N/A

Research impact score

Publications

0

Total publications

Trial Results

0

Published trial results

Citations

0

Total citations

Drug Portfolio

Analytics

Trial Phases

Phase 41

Trial Status

Completed2

Role Distribution

Principal Investigator2
PI Rate100%

Activity Timeline

Clinical Trials (2)

NCT01527279Phase 4Completed
Antazoline in Rapid Cardioversion of Paroxysmal Atrial Fibrillation
Paroxysmal Atrial Fibrillation
Principalinvestigator
NCT01594814Completed
Patients' Perspective on Radiofrequency Catheter Ablation of AVRT and AVNRT
Re-entrant Atrioventricular TachycardiaTachycardia, Atrioventricular Nodal Reentry
Principalinvestigator

Research Network

Collaboration Network

5 collaborators·5 connections
Network Legend
KOL
Current Investigator
CO
High-influence Collaborator
CO
Collaborator
Click: view details
Double-click: go to profile
Drag: move node

Research Areas & Affiliations

Affiliations

National Institute of Cardiology, Warsaw, Poland

Similar Key Opinion Leaders

Discover other key opinion leaders with similar research profiles, therapeutic areas, and collaboration networks.

10 similar investigators found

Mariusz Pytkowski, MD, PhD

National Institute of Cardiology, Warsaw, Poland

Related
1 trials

Shared therapeutic areas:

Re-entrant Atrioventricular TachycardiaTachycardia, Atrioventricular Nodal Reentry

Worked with same sponsors:

National Institute of Cardiology, Warsaw, Poland
Collaborated on 1 trial
Similarity Score24%

Stavros Stavrakis, MD

University of Oklahoma

Related
7 trials

Shared therapeutic areas:

Paroxysmal Atrial FibrillationTachycardia, Atrioventricular Nodal Reentry
Similarity Score20%

Hanna Szwed, MD, PhD

National Institute of Cardiology, Warsaw, Poland

Related
2 trials

Shared therapeutic areas:

Paroxysmal Atrial Fibrillation

Worked with same sponsors:

National Institute of Cardiology, Warsaw, Poland
Collaborated on 1 trial
Similarity Score14%

Aleksander Maciag, MD, PhD

National Institute of Cardiology, Warsaw, Poland

Related
1 trials

Shared therapeutic areas:

Paroxysmal Atrial Fibrillation

Worked with same sponsors:

National Institute of Cardiology, Warsaw, Poland
Collaborated on 1 trial
Similarity Score14%

Moussa Mansour

Massachusetts General Hospital

Related
1 trials

Shared therapeutic areas:

Paroxysmal Atrial Fibrillation
Similarity Score10%

Michael Cutler

Intermountain Health Care, Inc.

Related
1 trials

Shared therapeutic areas:

Paroxysmal Atrial Fibrillation
Similarity Score10%

Chris Ellis

VUMC

Related
1 trials

Shared therapeutic areas:

Paroxysmal Atrial Fibrillation
Similarity Score10%

Mikhail Samsonov

Chief Medical Officer, R-Pharm

Related
8 trials

Shared therapeutic areas:

Paroxysmal Atrial Fibrillation
Similarity Score10%

Vivek Reddy, MD

Icahn School of Medicine at Mount Sinai

Related
28 trials

Shared therapeutic areas:

Paroxysmal Atrial Fibrillation
Similarity Score10%

Tristram Bahnson

Duke University

Related
1 trials

Shared therapeutic areas:

Paroxysmal Atrial Fibrillation
Similarity Score10%

Publications (0)

No publications found for this investigator.

Clinical Trials (2)

Showing 2 of 2 trials

NCT01527279Phase 4PrincipalInvestigator

Antazoline in Rapid Cardioversion of Paroxysmal Atrial Fibrillation

Paroxysmal Atrial Fibrillation
Completed
NCT01594814PrincipalInvestigator

Patients' Perspective on Radiofrequency Catheter Ablation of AVRT and AVNRT

Re-entrant Atrioventricular TachycardiaTachycardia, Atrioventricular Nodal Reentry
Completed

All 2 trials loaded